259 related articles for article (PubMed ID: 33919870)
1. Molecular Simulation-Based Investigation of Highly Potent Natural Products to Abrogate Formation of the nsp10-nsp16 Complex of SARS-CoV-2.
Mohammad A; Alshawaf E; Marafie SK; Abu-Farha M; Al-Mulla F; Abubaker J
Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33919870
[TBL] [Abstract][Full Text] [Related]
2. A High-Throughput RNA Displacement Assay for Screening SARS-CoV-2 nsp10-nsp16 Complex toward Developing Therapeutics for COVID-19.
Perveen S; Khalili Yazdi A; Devkota K; Li F; Ghiabi P; Hajian T; Loppnau P; Bolotokova A; Vedadi M
SLAS Discov; 2021 Jun; 26(5):620-627. PubMed ID: 33423577
[TBL] [Abstract][Full Text] [Related]
3. A High-Throughput Radioactivity-Based Assay for Screening SARS-CoV-2 nsp10-nsp16 Complex.
Khalili Yazdi A; Li F; Devkota K; Perveen S; Ghiabi P; Hajian T; Bolotokova A; Vedadi M
SLAS Discov; 2021 Jul; 26(6):757-765. PubMed ID: 33874769
[TBL] [Abstract][Full Text] [Related]
4. Virtual screening, ADME/T, and binding free energy analysis of anti-viral, anti-protease, and anti-infectious compounds against NSP10/NSP16 methyltransferase and main protease of SARS CoV-2.
Maurya SK; Maurya AK; Mishra N; Siddique HR
J Recept Signal Transduct Res; 2020 Dec; 40(6):605-612. PubMed ID: 32476594
[TBL] [Abstract][Full Text] [Related]
5. Identification of naphthyridine and quinoline derivatives as potential Nsp16-Nsp10 inhibitors: a pharmacoinformatics study.
Aldahham BJM; Al-Khafaji K; Saleh MY; Abdelhakem AM; Alanazi AM; Islam MA
J Biomol Struct Dyn; 2022 Jun; 40(9):3899-3906. PubMed ID: 33252031
[TBL] [Abstract][Full Text] [Related]
6. Virtual screening and molecular dynamics simulation for identification of natural antiviral agents targeting SARS-CoV-2 NSP10.
Zhao H; Liu J; He L; Zhang L; Yu R; Kang C
Biochem Biophys Res Commun; 2022 Oct; 626():114-120. PubMed ID: 35988295
[TBL] [Abstract][Full Text] [Related]
7. Ligand and Structure-Based In Silico Determination of the Most Promising SARS-CoV-2 nsp16-nsp10 2'-
Eissa IH; Alesawy MS; Saleh AM; Elkaeed EB; Alsfouk BA; El-Attar AMM; Metwaly AM
Molecules; 2022 Mar; 27(7):. PubMed ID: 35408684
[TBL] [Abstract][Full Text] [Related]
8. Identification and Inhibition of the Druggable Allosteric Site of SARS-CoV-2 NSP10/NSP16 Methyltransferase through Computational Approaches.
Faisal S; Badshah SL; Kubra B; Sharaf M; Emwas AH; Jaremko M; Abdalla M
Molecules; 2022 Aug; 27(16):. PubMed ID: 36014480
[TBL] [Abstract][Full Text] [Related]
9. Molecular dynamic simulations reveal anti-SARS-CoV-2 activity of mitocurcumin by potentially blocking innate immune evasion proteins NSP3 and NSP16.
Pal D; Checker R; Kutala VK; Sandur SK
Mol Divers; 2023 Apr; 27(2):635-649. PubMed ID: 35538380
[TBL] [Abstract][Full Text] [Related]
10. Exploring the Catalytic Mechanism of the RNA Cap Modification by nsp16-nsp10 Complex of SARS-CoV-2 through a QM/MM Approach.
Silva JRA; Urban J; Araújo E; Lameira J; Moliner V; Alves CN
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008724
[TBL] [Abstract][Full Text] [Related]
11. Structure-Based Virtual Screening for Methyltransferase Inhibitors of SARS-CoV-2 nsp14 and nsp16.
Wu K; Guo Y; Xu T; Huang W; Guo D; Cao L; Lei J
Molecules; 2024 May; 29(10):. PubMed ID: 38792173
[TBL] [Abstract][Full Text] [Related]
12. Biochemical and structural insights into the mechanisms of SARS coronavirus RNA ribose 2'-O-methylation by nsp16/nsp10 protein complex.
Chen Y; Su C; Ke M; Jin X; Xu L; Zhang Z; Wu A; Sun Y; Yang Z; Tien P; Ahola T; Liang Y; Liu X; Guo D
PLoS Pathog; 2011 Oct; 7(10):e1002294. PubMed ID: 22022266
[TBL] [Abstract][Full Text] [Related]
13. Short peptides derived from the interaction domain of SARS coronavirus nonstructural protein nsp10 can suppress the 2'-O-methyltransferase activity of nsp10/nsp16 complex.
Ke M; Chen Y; Wu A; Sun Y; Su C; Wu H; Jin X; Tao J; Wang Y; Ma X; Pan JA; Guo D
Virus Res; 2012 Aug; 167(2):322-8. PubMed ID: 22659295
[TBL] [Abstract][Full Text] [Related]
14. New targets for drug design: importance of nsp14/nsp10 complex formation for the 3'-5' exoribonucleolytic activity on SARS-CoV-2.
Saramago M; Bárria C; Costa VG; Souza CS; Viegas SC; Domingues S; Lousa D; Soares CM; Arraiano CM; Matos RG
FEBS J; 2021 Sep; 288(17):5130-5147. PubMed ID: 33705595
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of SARS-CoV-2 nsp10-nsp16 in complex with small molecule inhibitors, SS148 and WZ16.
Klima M; Khalili Yazdi A; Li F; Chau I; Hajian T; Bolotokova A; Kaniskan HÜ; Han Y; Wang K; Li D; Luo M; Jin J; Boura E; Vedadi M
Protein Sci; 2022 Sep; 31(9):e4395. PubMed ID: 36040262
[TBL] [Abstract][Full Text] [Related]
16.
Eissa IH; Khalifa MM; Elkaeed EB; Hafez EE; Alsfouk AA; Metwaly AM
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684735
[TBL] [Abstract][Full Text] [Related]
17. Emerging variants of SARS-CoV-2 NSP10 highlight strong functional conservation of its binding to two non-structural proteins, NSP14 and NSP16.
Wang H; Rizvi SRA; Dong D; Lou J; Wang Q; Sopipong W; Su Y; Najar F; Agarwal PK; Kozielski F; Haider S
Elife; 2023 Dec; 12():. PubMed ID: 38127066
[TBL] [Abstract][Full Text] [Related]
18. Computational investigation of potent inhibitors against SARS-CoV-2 2'-O-methyltransferase (nsp16): Structure-based pharmacophore modeling, molecular docking, molecular dynamics simulations and binding free energy calculations.
Shi L; Wen Z; Song Y; Wang J; Yu D
J Mol Graph Model; 2022 Dec; 117():108306. PubMed ID: 36063745
[TBL] [Abstract][Full Text] [Related]
19. Binding of the Methyl Donor
Aouadi W; Blanjoie A; Vasseur JJ; Debart F; Canard B; Decroly E
J Virol; 2017 Mar; 91(5):. PubMed ID: 28031370
[TBL] [Abstract][Full Text] [Related]
20. Computational Analysis of SAM Analogs as Methyltransferase Inhibitors of nsp16/nsp10 Complex from SARS-CoV-2.
Balieiro AM; Anunciação ELS; Costa CHS; Qayed WS; Silva JRA
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
